𝔖 Bobbio Scriptorium

✦ LIBER ✦

NIH and NCI support for development of novel therapeutics in gynecologic cancer: A user's guide

✍ Scribed by Lucas Minig; Edward L. Trimble; Michael J. Birrer; Kelly Y. Kim; Naoko Takebe; Jeffrey S. Abrams

Book ID: 113962279
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 138 KB
Volume: 116
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2009.10.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical and clinical studies of estr

Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer

✍ Marion T Weigel, Zara Ghazoui, Anita Dunbier, Sunil Pancholi, Mitch Dowsett, Les 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 710 KB

[ACS Symposium Series] Galectins and Dis

[ACS Symposium Series] Galectins and Disease Implications for Targeted Therapeutics Volume 1115 || Translational Rational for the Clinical Development of OTX-008: A Novel Drug That Inhibits Galectin-1 Expression in Human Cancer Models

✍ Klyosov, Anatole A.; Traber, Peter G. 📂 Article 📅 2012 🏛 American Chemical Society ⚖ 244 KB

Genome-wide association study of prostat

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24: Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF, Hoover R, Hunter DJ, Chanock SJ, Thomas G, SAIC-Frederick, National Cancer Institute (NCI)-Frederick Cancer Research and Development Center, Frederick, MD; and Division of Cancer Epidemiology and Genetics, Center for Cancer Research, NCI, U.S. National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, MD

✍ Adam S. Kibel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 41 KB

In vitro evaluation of selected new comp

In vitro evaluation of selected new compounds as inhibitors of HIV-1 replication : M.A. Chirigos3, J.S. Driscoll2, J.B. Kahlon1, M. Tucker1, L.E. White1, A.D. Brazier1, and W.M. Shannon1. Southern Research Institute, Birmingham, AL 35255 USA1, Laboratory of Medicinal Chemistry, Division of Therapeutics Program, Division of Cancer Treatment, NCI, NIH, Bethesda, MD2, U.S. Army Medical Research, Institute of Infectious Diseases, Fort Detrick, Frederick, MD3

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Effect of comorbidity on risk of venous

Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma11The project described was supported by the National Center for Research Resources, United States, through Grant KL2TR000084 the National Center for Advancing Translational Sciences, United States, through Grant KL2TR000084 and the National Institutes of Health, United States, through Grant KL2TR000084, and a grant from the Danish Cancer Society (R73-A4284-13-S17) and from the Karen Elise Jensen Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH and the Clinical Epidemiological Research Foundation.

✍ Smith, Angela B.; Horvath-Puhó, Erzsébet; Nielsen, Matthew E.; Lash, Timothy L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 220 KB